Imagine a world where your fitness tracker or smart watch never needs to be recharged, not because it has a battery that ...
Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the ...
Join us in Minneapolis to hear more from keynote speaker Lisa Earnhardt, at DeviceTalks Minnesota on May 4, 2026.
All Penny Stocks (English) on MSN
Microcap medtech moving on US clinical milestone
Advancements in diabetes technology continue to accelerate as companies race to improve patient outcomes and quality of life.
Glucotrack (Nasdaq:GCTK) today provided an update on the planned regulatory timeline for its continuous blood glucose monitor ...
Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...
Advances in microfluidic biosensors and materials science transformed sweat into a reliable, high-quality data stream capable ...
The global insulin delivery devices market is experiencing strong expansion as the prevalence of diabetes continues to rise worldwide. Insulin delivery devices play a crucial role in managing blood ...
Transitioning from multiple daily injections to a tubeless automated insulin delivery (AID) system significantly improves HbA1c in T1D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results